Category: Blog
DNAS and Fluidigm Partner in Distribution Pact for CopyCount
Agreement:
NEW YORK (GenomeWeb) – Fluidigm said today that it has entered into a non-exclusive distribution agreement with DNA Software to provide that firm’s CopyCount-CNV software for use with Fluidigm’s Biomark HD system.
Biomark HD is an automated qPCR platform that uses microfluidics to detect CNVs in tens to hundreds of samples with significant cost and time savings over traditional plate‑based methods, according to Fluidigm.
CopyCount-CNV:
DNA Software’s CopyCount-CNV complements the Biomark HD workflow by enabling researchers to measure CNVs with high accuracy by determining the absolute copy number of each marker from raw fluorescence qPCR data and computing the ratio of those copy numbers to reveal the CNV.
Accurate CNV:
The combination of the easy-to-use CopyCount-CNV software and the proven, high-performance Biomark HD automated qPCR system from Fluidigm has the potential to result in more accurate CNV determination in both translational and clinical research, John SantaLucia, co-founder, president, and CEO of DNA Software, said in a statement.
DNAS featured in Nature publication
Article in Nature:
DNA Software was featured in a recent article published in Nature on July 16, 2018 titled “Multiplexed identification, quantification and genotyping of infectious agents using a semiconductor biochip”. To learn more click here
DNAS Referenced in Biology Methods & Protocols
Biology Methods & Protocols:
DNA Software Acknowledged and Referenced in Biology Methods & Protocols paper titled “An array-based melt curve analysis method for the identification and classification of closely related pathogen strains”.
DNA Software Fall 2019 Newsletter
Fall 2019 newsletter
Click here to download a pdf copy of the DNA Software Fall Newsletter
DNA Software presents PanelPlex at TriCon
Large Scale Multiplex PCR Panel Design
Large Scale Multiplex PCR Panel Design with >95% Success in Hours, Not Months
John SantaLucia, Ph.D., co-founder and CEO, DNA Software
Abstract: We aim to solve the problem of multiplex PCR design by a three-pronged approach: 1. improved understanding of the mechanism of PCR and the causes of artifacts, 2. improved algorithms for predicting secondary structure and mis-hybridization, and 3. implementation of cloud to address large sequence databases. These approaches vastly improve the success of fully automated multiplex PCR design with larger plex sizes. This enables applications such as targeted enrichment for NGS and infectious disease molecular diagnostics.
DNA Software announces launch of PanelPlex
DNAS releases PanelPlex
Infectious disease molecular diagnostic(MDx) assays require rapid identification of pathogens and their drug resistance profiles in clinical samples use a highly multiplexed molecular approach. The market pull for such MDx assays has led to the software solution, PanelPlexTM.
Ann Arbor, MI – June 7, 2017.
DNAS releases PanelPlex™ , a cloud based product to solve the four most common problems in multiplex. PanelPlex™ was built in direct response to the molecular diagnostics customers that DNA Software has served over the past two decades. These multiplex problems include lost time in design and time to market, costs related to lengthy design, lack of organizational expertise and the use of sub-optimal tools and freeware. PanelPlex™ is designed to solve the tough problems that are problematic for “freeware”.
There are two options for customers. One is to use the product directly utilizing cloud-computing. The other option is to have DNA Software use the software to do all the design work. Some customers opt for hands-on work, others want a concierge service utilizing DNA Software’s team of professionals.
“We are very excited to offer the most comprehensive software product with exactly the right functionality and user experience for researchers designing panels. PanelPlex™ is the result of 15 years of investigation into the mechanism of PCR and careful experiments to identify the sources of failure of PCR” commented CEO, Dr. John SantaLucia.
About DNAS
About DNA Software Inc.
Over 20 years ago, Dr. John SantaLucia made significant discoveries at a prestigious research university regarding the behavior of DNA and his seminal published work has now been cited over 5000 times. DNA Software, Inc. was founded to commercialize this research for real market applications by the accuracy of predictive models into software algorithms to replace traditional trial and error experimentation. DNA Software (DNAS) has now offered solutions to some of the most difficult problems in DNA Diagnostic Design and Analysis, first in desktop software and now in cloud based applications.
DNA Software receives FastTrack award
DNA Software receives FastTrack award
ANN ARBOR, MICH. – At its annual meeting, Ann Arbor SPARK presented its annual FastTrack awards to 17 Washtenaw County-based companies that have demonstrated fast growth. Several of the 2016 and 2017 FastTrack award recipients were multiple year winners.
“It’s incredible to see the range of companies that are thriving in our region,” said Paul Krutko, president and CEO of Ann Arbor SPARK. “The achievement of FastTrack companies is truly remarkable: They all maintained year over year growth for three consecutive years. These leading businesses prove that Ann Arbor offers what companies need to be successful.”
Yeo & Yeo CPAs & Business Consultants sponsors the Ann Arbor SPARK FastTrack Awards and verified all of the award applications.
About Ann Arbor SPARK
Ann Arbor SPARK, a non-profit organization, is advancing the region by encouraging and supporting business acceleration, attraction and retention. The organization identifies and meets the needs of business at every stage, from start-ups to large organizations. Ann Arbor SPARK collaborates with business, academic, government, and community investor partners including the University of Michigan, Eastern Michigan University, Washtenaw Community College, Washtenaw County,
DNAS cited in Science Advances
DNAS cited in Science Advances
Early identification of pathogens is essential for limiting development of therapy-resistant pathogens and mitigating infectious disease outbreaks. Most bacterial detection schemes use target-specific probes to differentiate pathogen species, creating time and cost inefficiencies in identifying newly discovered organisms. We present a novel universal microbial diagnostics (UMD) platform to screen for microbial organisms in an infectious sample, using a small number of random DNA probes that are agnostic to the target DNA sequences. Our platform leverages the theory of sparse signal recovery (compressive sensing) to identify the composition of a microbial sample that potentially contains novel or mutant species. We validated the UMD platform in vitro using five random probes to recover 11 pathogenic bacteria. We further demonstrated in silico that UMD can be generalized to screen for common human pathogens in different taxonomy levels. UMD’s unorthodox sensing approach opens the door to more efficient and universal molecular diagnostics.
Rice University group publishes on universal microbial diagnostics (UMD) recently in Science Advances
Copy Number Variation Case Study – Assure-CNV
Increase Accuracy of Assure-CNV
A world class agricultural company compared the capabilities of Assure-CNV to their current workflow. This customer found Assure-CNV increased accuracy with 12 standard deviations versus the 8 provided by their traditional method. Their standard workflow also required several days to organize the data for statistical analysis, whereas Assure-CNV accurately called 100% of the samples within a few minutes. As a high throughput lab running millions of samples, Assure CNV provided a significant improvement in accuracy while reducing time and cost compared to their previous method. The Assure-CNV product was found to help the determination of transgene copy number and event sorting and ultimately impacting the confidence of the seed zygosity calls that will be made downstream.
Antisense Webinar Transcript
Better Antisense Design Without the Trial and Error: Problems we Solve
Most researchers use naïve strategies to design antisense oligonucleotides. However, to maximize assay sensitivity and specificity one must consider probe and target sequence and their respective and combined chemistries. That is why DNA Software has built the Antisense Architect design and simulation platform for the rational design of Antisense Oligonucleotide Analogs. Three problems that we solve are the proper evaluation of Target Accessibility and sensitivity, the minimization off-target effects that elicit immune responses and often cell death, and we have the necessary thermodynamic libraries to predict the proper use of Chemical Modifications to prevent enzymatic digestion.
Target Accessibility: The Conventional Approach to Duplex Formation
The naïve way to design Antisense Oligonucleotides is to only consider the two-state model of probe hybridization which describes the probe and its hybridization to its complement. Target accessibility and tail folding are not accounted for, therefore this is an incomplete model of what is really happening in the system which leads to a lack of sensitivity due to target and probe secondary structure and negates the effect of bimolecular mishybridization reactions.
Competing Secondary Structure-False-Negative Assays
The platform for each of our DNA Software products is based on the multi-state equilibrium model which accounts for the energetic cost of target and probe secondary structure through coupled equilibria, which ultimately increases assay sensitivity. This means that the Antisense Architect will evaluate and thermodynamically score your desired design sites, and if given an entire target, it will identify all thermodynamically accessible sites.
Off-Target Effects: Using ThermoBLAST to Predict Crosshybridization and Mishybridization
Many researchers use NCBI BLAST for their oligonucleotide design because its free, but even free has its associated costs because BLAST is the wrong tool for determining selectivity. BLAST was meant to determine common evolutionary ancestry through sequence similarity, however sequence similarity does not equal thermodynamic stability as BLAST does not account for thermodynamic contributions of basepairing and mismatches, target bulges and dangling ends and different oligo backbone chemistries. DNA Software’s products take all of the aforementioned thermodynamic contributions into account in both the design and simulation of Antisense oligonucleotide analogs, which results in a more accurate prediction of oligonucleotide mishybridization and crosshybridization.
Chemical Modification: Packages are Customizable
It is well documented that the key to preventing the enzymatic digestion of Antisense oligonucleotides, or in some cases immune stimulation, lays in the chemical substitution of the probe backbone or 2’ sugar moieties. What is not well documented is the thermodynamic libraries required for rational design that takes into account the thermodynamic contributions of the modifications listed that predict probe secondary structure and the energy of hybridization and ultimately the melting temperature, or Tm. Depending on the modifieds used the Tm could differ by as much as +/- 10 degrees celcius, which may have an unwanted and undefined effect on your assay if you are not able to simulate the use of modifieds in design. DNA Software has determined the thermodynamic effects of the listed modifieds and is prepared to build an Antisense Architect Platform that is specific to your research needs and requirements.
DNA Software’s Antisense Architect
The recurring issues of Target accessibility, Probe design, Off-target effects and the proper use of chemical modifications are solved in the Antisense Architect which uses design heuristics that allows for the rational design of Antisense oligonucleotides. Some heuristics that are used in design include the evaluation of secondary structure and sequence composition and complexity of targets and probes. We will discuss the design heuristics in more detail when we review the design results of our demo.
Antisense Architect: 4 easy steps
The Antisense Architect use a design wizard format to collect necessary input from the user for the design of highly sensitive and selective Antisense probes in four easy steps:
-Choose the background RefSeq of interest and the target
-Choose target design region
-Choose desired probe chemistry and hybridization conditions
-Run the job and get results.
And now…the Antisense Architect Demo!